相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Molecular Genetic Testing in Endocrinology - A Practical Guide
Salman Kirmani
Endocrine Practice (2013)
Assembly of Protein Building Blocks Using a Short Synthetic Peptide
Enrico Ferrari et al.
BIOCONJUGATE CHEMISTRY (2012)
Presynaptic neurotoxins: An expanding array of natural and modified molecules
Bazbek Davletov et al.
CELL CALCIUM (2012)
Adrenal neoplasms
G. Low et al.
CLINICAL RADIOLOGY (2012)
Immunocombination therapy for high-risk neuroblastoma
Michiel Kroesen et al.
IMMUNOTHERAPY (2012)
A botulinum toxin-derived targeted secretion inhibitor downregulates the GH/IGF1 axis
Emmanuel Somm et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Single Reconstituted Neuronal SNARE Complexes Zipper in Three Distinct Stages
Ying Gao et al.
SCIENCE (2012)
Microarray analysis of differentially regulated genes in human neuronal and epithelial cell lines upon exposure to type A botulinum neurotoxin
Nagarajan Thirunavukkarasu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Novel proteins: from fold to function
Betsy A. Smith et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2011)
Pancreatic Neuroendocrine Tumors
Elizabeth Batcher et al.
ENDOCRINE RESEARCH (2011)
Dynamin Inhibition Blocks Botulinum Neurotoxin Type A Endocytosis in Neurons and Delays Botulism
Callista B. Harper et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Cardiovascular manifestations of phaeochromocytoma
Aleksander Prejbisz et al.
JOURNAL OF HYPERTENSION (2011)
Re-Assembled Botulinum Neurotoxin Inhibits CNS Functions without Systemic Toxicity
Enrico Ferrari et al.
TOXINS (2011)
Towards New Uses of Botulinum Toxin as a Novel Therapeutic Tool
Andy Pickett et al.
TOXINS (2011)
Temperature dependent photolabeling of the human angiotensin II type 1 receptor reveals insights into its conformational landscape and its activation mechanism
Jason Arsenault et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Central modulation of pain
Michael H. Ossipov et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Growth Suppression of Mouse Pituitary Corticotroph Tumor AtT20 Cells by Curcumin: A Model for Treating Cushing's Disease
Madhavi Latha Yadav Bangaru et al.
PLOS ONE (2010)
SNARE tagging allows stepwise assembly of a multimodular medicinal toxin
Frederic Darios et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Targeted Secretion Inhibitors-Innovative Protein Therapeutics
Foster Keith et al.
TOXINS (2010)
Prevalence and Incidence of Endocrine and Metabolic Disorders in the United States: A Comprehensive Review
Sherita H. Golden et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Cell entry strategy of clostridial neurotoxins
Thomas Binz et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Engineering botulinum neurotoxin to extend therapeutic intervention
Sheng Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Membrane Fusion: Grappling with SNARE and SM Proteins
Thomas C. Sudhof et al.
SCIENCE (2009)
The biological characterization of neuroendocrine tumors: The role of neuroendocrine markers
P. Ferolla et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2008)
Long-distance retrograde effects of botulinum neurotoxin A
Flavia Antonucci et al.
JOURNAL OF NEUROSCIENCE (2008)
Microenvironmental Determinants of Adult Neural Stem Cell Proliferation and Lineage Commitment in the Healthy and Injured Central Nervous System
Emmanuel Moyse et al.
CURRENT STEM CELL RESEARCH & THERAPY (2008)
Peptide-labeled quantum dots for imaging GPCRs in whole cells and as single molecules
Min Zhou et al.
BIOCONJUGATE CHEMISTRY (2007)
Mesodermal cell types induce neurogenesis from adult human hippocampal progenitor cells
Andreas Hermann et al.
JOURNAL OF NEUROCHEMISTRY (2006)
The synaptic vesicle protein 2C mediates the uptake of botulinum neurotoxin A into phrenic nerves
S Mahrhold et al.
FEBS LETTERS (2006)
Re-engineering the target specificity of clostridial neurotoxins - a route to novel therapeutics
KA Foster et al.
NEUROTOXICITY RESEARCH (2006)
Clostridial neurotoxins: structure-function led design of new therapeutics
JA Chaddock et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2006)
Promiscuous interaction of SNAP-25 with all plasma membrane syntaxins in a neuroendocrine cell
M Bajohrs et al.
BIOCHEMICAL JOURNAL (2005)
Fluorophore-tagged GPCR ligands
RJ Middleton et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2005)
Beyond BOTOX: advantages and limitations of individual botulinum neurotoxins
B Davletov et al.
TRENDS IN NEUROSCIENCES (2005)
A new wrinkle on pain relief: re-engineering clostridial neurotoxins for analgesics
KA Foster
DRUG DISCOVERY TODAY (2005)
Retargeted clostridial endopeptidases: Inhibition of nociceptive neurotransmitter release in vitro, and antinociceptive activity in in vivo models of pain
JA Chaddock et al.
MOVEMENT DISORDERS (2004)
Pheochromocytoma and myocardial infarction
A Garg et al.
SOUTHERN MEDICAL JOURNAL (2004)
A molecular basis underlying differences in the toxicity of botulinum serotypes A and E
M Bajohrs et al.
EMBO REPORTS (2004)
Dynamics of motor nerve terminal remodeling unveiled using SNARE-cleaving botulinum toxins: the extent and duration are dictated by the sites of SNAP-25 truncation
FA Meunier et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2003)
Botulinum neurotoxin A activity is dependent upon the presence of specific gangliosides in neuroblastoma cells expressing synaptotagmin I
BC Yowler et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Inhibition of vesicular secretion in both neuronal and nonneuronal cells by a retargeted endopeptidase derivative of Clostridium botulinum neurotoxin type A
JA Chaddock et al.
INFECTION AND IMMUNITY (2000)